Engineering viral genomics and nano-liposomes in microfluidic platforms for patient-specific analysis of SARS-CoV-2 variants
SARS-CoV-2 변이체의 환자별 분석을 위한 미세유체 플랫폼에서 바이러스 게놈 및 나노 리포솜 엔지니어링
Review
Published on
Journal: Theranostics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술, 치료제,
Journal: Theranostics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, 치료기술, 치료제,
[키워드] (Alpha)
(Beta)
accelerate
ACE2
acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Alpha
Analysis
angiotensin
Angiotensin-converting enzyme
angiotensin-converting enzyme 2
B.1.1.529
B.1.351
B.1.617.2
Beta
binding
Blood
Cell culture
Coagulation
contributing to
Conventional
coronavirus
COVID-19
COVID-19 pandemic
Delta
encapsulate
Engineering
ethical concern
ethical concerns
genomic sequence
glycoprotein
highlight
host cell
host cells
Increasing
Lambda
Microfluidics
mutations
mutations, variants of concerns
nano-liposomes
Neutralizing antibodies
neutralizing antibody
New
omicron
optimization
organ
Organ on-a-chip
organ-specific
pathogenicity
persistence
platform
predict
primates
Protein
recent
Reinfection
resource
respiratory
rising
SARS-CoV-2
SARS-CoV-2 Spike mutation
SARS-CoV-2 spike mutations
SARS-CoV-2 spike protein
SARS-CoV-2 variant
SARS-CoV-2 variants
SARS-CoV-2 viral
severe acute respiratory syndrome Coronavirus
spike
spike glycoprotein
spike mutations
Spike protein
Spread
strength
the Spike
therapeutic target
therapeutic targets
Therapeutics
Transmissibility
two-dimensional
unmet need
vaccination
Vaccine
variant
variants
Viral
viral genomics
viral infection
Viral variants
[DOI] 10.7150/thno.72339 PMC 바로가기 [Article Type] Review
[DOI] 10.7150/thno.72339 PMC 바로가기 [Article Type] Review